Literature DB >> 4380733

Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice.

G W Siskind, J G Howard.   

Abstract

1. Comparison of dose-response curves indicated that preimmunized animals were slightly more susceptible to the induction of immunological paralysis with pneumococcal polysaccharide than were normal mice. The results also indicated that the paralysis threshold was unaltered by preimmunization. 2. Transient desensitization of immunized mice could be achieved by an amount of polysaccharide far less than that required to induce paralysis. 3. A transient phase of weak immunity was detected prior to the onset of paralysis when induced by relatively low paralyzing doses of polysaccharide. 4. No "low dose" zone of paralysis (analogous to that obtainable with certain protein antigens) could be elicited with pneumococcal polysaccharide. 5. Massive proliferation of lymphoreticular tissues induced by Corynebacterium parvum failed to raise the threshold for paralysis induction, but amplified the immune response over the entire dose-response curve. Similarly, C. parvum failed to abrogate an established state of paralysis. The results suggest that the induction of polysaccharide paralysis is related to the concentration of antigen in the animal and is not modified by the number of immunologically competent cells.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4380733      PMCID: PMC2138240          DOI: 10.1084/jem.124.3.417

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  IMMUNOLOGIC TOLERANCE AFTER SPECIFIC IMMUNIZATION.

Authors:  M M DORNER; J W UHR
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

2.  RECOGNITION OF FOREIGNNESS IN IMMUNE AND TOLERANT ANIMALS.

Authors:  G J NOSSAL; G L ADA
Journal:  Nature       Date:  1964-02-08       Impact factor: 49.962

3.  THE INDUCTION OF IMMUNOLOGICAL TOLERANCE AFTER SPECIFIC ANTIBODY FORMATION.

Authors:  M M DORNER; J W UHR
Journal:  Ann N Y Acad Sci       Date:  1964-11-30       Impact factor: 5.691

4.  THE EFFECT OF ANTIGEN ON THE PROLIFERATION OF SPLEEN CELL SUSPENSIONS FROM TOLERANT RABBITS.

Authors:  R W DUTTON
Journal:  J Immunol       Date:  1964-11       Impact factor: 5.422

5.  Pneumococcal antigenic polysaccharide substances from animal tissues.

Authors:  L D FELTON; B PRESCOTT; G KAUFFMANN; B OTTINGER
Journal:  J Immunol       Date:  1955-03       Impact factor: 5.422

6.  Transplantation tolerance and immunological immaturity.

Authors:  D MICHIE; J G HOWARD
Journal:  Ann N Y Acad Sci       Date:  1962-10-24       Impact factor: 5.691

7.  The suppressive effect of supraoptimum doses of antigen on the secondary antibody-forming response of spleen cells cultured in cell-impermeable diffusion chambers.

Authors:  T Makinodan; I Hoppe; T Sado; E E Capalbo; M R Leonard
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

8.  HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT.

Authors:  D A ROWLEY; F W FITCH
Journal:  J Exp Med       Date:  1964-12-01       Impact factor: 14.307

9.  Localization of antigen in tissue cells; cellular distribution of pneumococcal polysaccharides types II and III in the mouse.

Authors:  M E KAPLAN; A H COONS; H W DEANE
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

10.  ANTIBODY FORMATION IN VOLUNTEERS FOLLOWING INJECTION OF PNEUMOCOCCI OR THEIR TYPE-SPECIFIC POLYSACCHARIDES.

Authors:  M Heidelberger; C M Macleod; S J Kaiser; B Robinson
Journal:  J Exp Med       Date:  1946-03-31       Impact factor: 14.307

View more
  17 in total

1.  Tolerance to thymus-independent antigens. Characteristics of induction of tolerance to thymus-independent synthetic polypeptides.

Authors:  E Mozes; M Sela; M J Taussig
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

2.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

3.  Immunological paralysis of mice with pneumococcal polysaccharide antigens.

Authors:  W J Halliday
Journal:  Bacteriol Rev       Date:  1971-09

4.  Studies on immunological paralysis. V. The influence of molecular weight on the immunogenicity, tolerogenicity and antibody-neutralizing activity of the 3 pneumococcal polysaccharide.

Authors:  J G Howard; H Zola; G H Christie; B M Courtenay
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

5.  Studies on immunological paralysis. I. A consideration of macrophage involvement in the induction of paralysis and immunity by type II pneumococcal polysaccharide.

Authors:  J G Howard; G W Siskind
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

6.  Immunological unresponsiveness of guinea pigs to major antigens in heterologous whole serum.

Authors:  A A Codd; J H Hale; J B Selkon; H R Ingham
Journal:  Br J Exp Pathol       Date:  1968-08

7.  The dosage requirements for immunological paralysis by soluble proteins.

Authors:  N A Mitchison
Journal:  Immunology       Date:  1968-10       Impact factor: 7.397

8.  Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits.

Authors:  R N Pinckard; D M Weir; W H McBride
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

9.  Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens.

Authors:  J Kovarik; P Bozzotti; C Tougne; H L Davis; P H Lambert; A M Krieg; C A Siegrist
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

10.  Studies on immunological paralysis. IX. The immunogenicity and tolerogenicity of levan (polyfructose) in mice.

Authors:  J J Miranda
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.